(Q42281252)

19 October 2017

MBX-500, a hybrid antibiotic with in vitro and in vivo efficacy against toxigenic Clostridium difficile (English)

1 reference

19 October 2017

Clostridium difficile

object named as

Clostridium difficile

1 reference

8

1 reference

19 October 2017

3

Diane M Citron

1 reference

19 October 2017

Michelle M Butler

1

1 reference

19 October 2017

Dean L Shinabarger

2

1 reference

19 October 2017

Ciarán P Kelly

4

1 reference

19 October 2017

Sofya Dvoskin

5

1 reference

19 October 2017

George E Wright

6

1 reference

19 October 2017

Hanping Feng

7

1 reference

19 October 2017

Terry L Bowlin

9

1 reference

19 October 2017

language of work or name

English

0 references

publication date

25 June 2012

1 reference

Antimicrobial Agents and Chemotherapy

19 October 2017

1 reference

19 October 2017

56

1 reference

19 October 2017

9

1 reference

19 October 2017

4786-4792

1 reference

Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Fidaxomicin: a macrocyclic antibiotic for the treatment of Clostridium difficile infection

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Mouse relapse model of Clostridium difficile infection

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Future novel therapeutic agents for Clostridium difficile infection

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Clostridium difficile--more difficult than ever

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

A mouse model of Clostridium difficile-associated disease

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Hybrid antibacterials. DNA polymerase-topoisomerase inhibitors

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

An epidemic, toxin gene-variant strain of Clostridium difficile

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Dual beta-lactam-fluoroquinolone compounds: a novel approach to antibacterial treatment

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing Clostridia

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Metronidazole resistance in Clostridium difficile is heterogeneous

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Synthesis and antibacterial activity of 3-substituted-6-(3-ethyl-4-methylanilino)uracils

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Structure–activity relationship in the oxazolidinone–quinolone hybrid series: influence of the central spacer on the antibacterial activity and the mode of action

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Recurrence of symptoms in Clostridium difficile infection--relapse or reinfection?

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421853

Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain

17 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22733075

12 December 2020

inferred from PubMed ID database lookup

New drugs for Clostridium difficile infection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22733075

12 December 2020

inferred from PubMed ID database lookup

The new Clostridium difficile--what does it mean?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22733075

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.00508-12

1 reference

release_jdmkxp3y35ak7ddj6ocpsdfzvq

19 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jdmkxp3y35ak7ddj6ocpsdfzvq

24 November 2022

mapped directly with Wikidata item

1 reference

19 October 2017

PubMed publication ID

22733075

1 reference